Skip to main content

TNF inhibitor

Podcast microphone headphones
Day 1 (part one): ACR 2019 Podcast
RheumNow
Panel Presentation: Psoriatic Arthritis

Drs. Eric Ruderman, Alexis Ogdie, Jessica Walsh, and Jose Scher discuss the giselkumab trials, where IL-23 inhibitors fit in practice, ixekizumab withdrawal, and more that presented at the 2019 ACR/ARP annual meeting in Atlanta. 

vaccine shot
Herpes Zoster Vaccine Update
Cassandra Calabrese, DO
Shingrix (GSK), the herpes zoster subunit vaccine (a two-shot series), was approved by the FDA in Fall 2018 and is currently approved for use in adults 50 years and older. Shingrix has replaced the…
RT @hausmannMD: Holy Molly! TNFi (etanercept, adalimumab, infliximab, or golimumab) completely prevented stokes in patients with DADA2. #AC…

Jonathan Hausmann MD hausmannMD

6 months 2 weeks ago

Holy Molly! TNFi (etanercept, adalimumab, infliximab, or golimumab) completely prevented stokes in patients with DADA2. #ACR19 @RheumNow

RT @Janetbirdope: Infections In out patients are increased as measured by antimicromial scripts with RA and TNFi use comparing popn control…

Janet Pope Janetbirdope

6 months 2 weeks ago

Infections In out patients are increased as measured by antimicromial scripts with RA and TNFi use comparing popn controls and pre and post RA TNFi use in pan Iceland registry #ACR19 #ACR @RheumNow abstr 2873. Higher than controls pre &even more after TNFi https://t.co/SlkIPP9WsJ

RT @uptoTate: Icelandic study shows RA pts use more antimicrobials in the 2 yrs prior to TNFi tx and have increased use 2 yrs after tx. htt…

Dr. Rachel Tate uptoTate

6 months 2 weeks ago

Icelandic study shows RA pts use more antimicrobials in the 2 yrs prior to TNFi tx and have increased use 2 yrs after tx. https://t.co/GyUdQT2NvD abs#2873 #ACR19 @RheumNow https://t.co/HKU2IOPwcw

RT @DrKanikaMonga: - Risk of bDMARD withdrawal higher for TNFi monotherapycompared w/ cs/bDMARD combination- If monotherapy necessary, et…

Kanika Monga, MD DrKanikaMonga

6 months 2 weeks ago

- Risk of bDMARD withdrawal higher for TNFi monotherapy compared w/ cs/bDMARD combination - If monotherapy necessary, etanercept should be preferred over infliximab and adalimumab Silvagni E et al. BMJ Open 2018 #ACR19 @RheumNow

RT @MaeveGamble: Abstr#2273: higher placental transfer antiTNFs=ADA,IFX,GOL. Less transfer=CTZ,ETN. No ⬆️ in infxns in offspring, even with…

Maeve Gamble MaeveGamble

6 months 2 weeks ago

Abstr#2273: higher placental transfer antiTNFs=ADA,IFX,GOL. Less transfer=CTZ,ETN. No ⬆️ in infxns in offspring, even with 3rd tri exposure. Potential trend for ⬆️ in serious infxns (>/=1 hosp adm 1st yr of life) with high placental transfer antiTNFs, not sig. #ACR2019 @RheumNow https://t.co/qEIl9lxlv1

RT @synovialjoints: 5-year effectiveness of TNFi in patients with early axSpA shown, male gender, HLAB27 positive and presence of at least…

Dr. Antoni Chan synovialjoints

6 months 2 weeks ago

5-year effectiveness of TNFi in patients with early axSpA shown, male gender, HLAB27 positive and presence of at least one objective sign of inflammation or structural damage are more frequently associated with effectiveness #2776 by Molto #ACR19 @RheumNow

RT @KDAO2011: #acrbest @rheumnow #acr19 abstr#1901VERY IMPT STUDY: 16,490 offspring of moms w/Rheum Dz: 105 on nonTNFi biologic or TOFA:…

k dao KDAO2011

6 months 3 weeks ago

#acrbest @rheumnow #acr19 abstr#1901 VERY IMPT STUDY: 16,490 offspring of moms w/Rheum Dz: 105 on nonTNFi biologic or TOFA: NO ⬆️in utero SIE . Only 2 cases of SIE- 1 w/TOFA &1 w/ABT. Risk for SIE in utero For healthy 1.6% For TNFi 2.3% For nonTNFi + TOFA 2.1%

light bulb thought
ACR 2019 - Report from Day One (Sunday)
Jack Cush, MD
Sunday was the first full day of scientific sessions at the 2019 ACR/ARP meeting in Atlanta. Yesterday we shared our initial news articles, videos and more with you. Following is my roundup of day…
A Focus on WOCBA (Women of Childbearing Age)
Maeve Gamble, MD
Many rheumatic diseases affect women of childbearing age. In the age of biologic therapy, women are achieving better disease activity and there are increasing numbers of women with rheumatic diseases…
RT @synovialjoints: Does anti-TNF treatment halt radiographc progression in ankylosing spondylitis? #ACR19 @RheumNow Vote here 👇

Dr. Antoni Chan synovialjoints

6 months 3 weeks ago

Does anti-TNF treatment halt radiographc progression in ankylosing spondylitis? #ACR19 @RheumNow Vote here 👇

RT @DrPetryna: Do you routinely use TNF inhibitors in your autoimmune patients with preexisting CHF?

Olga Petryna DrPetryna

6 months 3 weeks ago

Do you routinely use TNF inhibitors in your autoimmune patients with preexisting CHF?

RT @synovialjoints: 2 papers looking at TNFi on radiographic progression in Ankylosing Spondylitis. TNF inhibitor treatment slowed radiolog…

Dr. Antoni Chan synovialjoints

6 months 3 weeks ago

2 papers looking at TNFi on radiographic progression in Ankylosing Spondylitis. TNF inhibitor treatment slowed radiologic progression when compared to other therapies but covariables such as smoking and NSAIDs need to be considered #ACR19 @RheumNow

×